(2002). Pharmacogenomics: a critical component of patient stratification during drug development. Expert Review of Molecular Diagnostics: Vol. 2, No. 1, pp. 1-4.
No takes yet. Share an insight, caveat, or question.
Michael P. Murphy (2002) studied this question.